中国组织工程研究

中国组织工程研究 ›› 2011, Vol. 15 ›› Issue (31): 5789-5792.doi: 10.3969/j.issn.1673-8225.2011.31.021

• 肾移植 kidney transplantation • 上一篇    下一篇

丙型肝炎病毒阳性受者肾移植后的安全性分析

毕文浩，陈  正，马俊杰，方佳丽，李光辉，徐  璐，张  磊，艾  威，李德胜，潘光辉   

  1. 广州医学院第二附属医院肾移植科，广东省广州市　510260
  • 收稿日期:2011-01-15 修回日期:2011-04-11 出版日期:2011-07-30 发布日期:2011-07-30
  • 通讯作者: 潘光辉，硕士，教授，广州医学院第二附属医院肾移植科，广东省广州市　510260 shibingyi@medmail.com.cn
  • 作者简介:毕文浩，男，1984年生，山东省淄博市人，汉族，2008年泰山医学院毕业，主要从事泌尿外科-肾移植方面的研究。 bwh6683163@163.com

Safety analysis on kidney transplantation in hepatitis C virus-positive patients 

Bi Wen-hao, Chen Zheng, Ma Jun-jie, Fang Jia-li, Li Guang-hui, Xu Lu, Zhang Lei, Ai Wei, Li De-sheng, Pan Guang-hui   

  1. Department of Kidney Transplantation, Second Affiliated Hospital of Guangzhou Medical College, Guangzhou   510260, Guangdong Province, China
  • Received:2011-01-15 Revised:2011-04-11 Online:2011-07-30 Published:2011-07-30
  • Contact: Pan Guang-hui, Master, Professor, Department of Kidney Transplantation, Second Affiliated Hospital of Guangzhou Medical College, Guangzhou 510260, Guangdong Province, China
  • About author:Bi Wen-hao, Department of Kidney Transplantation, Second Affiliated Hospital of Guangzhou Medical College, Guangzhou 510260, Guangdong Province, China bwh6683163@163.com

PDF

368

被引次数

4

摘要：

背景：对于丙肝病毒阳性患者接受肾移植后安全性的问题是目前大家关注的热点。
目的：丙型肝炎病毒感染者接受肾移植后临床观察及处理对策。
方法：纳入22例患者，肾移植前肝炎病毒RNA均为阳性，其中14例患者肝功能轻度升高。移植后定期检测患者的肝、肾功能，积极防治可能的排斥反应。主要观察患者一般情况、肝、肾功能、肝炎病毒基因学情况及死亡率。
结果与结论：移植后随访6~36个月，20例患者移植后4周~6个月内出现不同程度的肝功能异常，予护肝治疗后肝功能均恢复正常，1例移植后HCV-RNA 阳性患者，因自行改变抗排斥方案于移植后1.5年出现严重的肝功能衰竭而死亡；4例患者移植后应用干扰素和利巴韦林治疗，HCV-RNA转阴，其余18例患者HCV-RNA均呈阳性，需长期护肝治疗。表明，对丙肝病毒阳性受者，移植后应进行严格的随访，出现肝功能异常时，及时采取相应处理和护肝治疗。

关键词: 丙型肝炎病毒, 肾移植, 感染, 肝功能异常, 排斥反应

Abstract:

BACKGROUND: Safety of kidney transplantation in hepatitis C virus (HCV)-positive patients has been paid increasing attention.
OBJECTIVE: To study the clinical observation and treatment strategy in HCV RNA-positive patients after kidney transplantation.
METHODS: A total of 22 HCV RNA-positive patients were involved in this study, of which 14 patients had mild liver dysfunction. The patients' liver and kidney function were detected regularly and corresponding doses and types of the anti-immune rejection drug were adjusted in time to prevent possible immunological rejections.
RESULTS AND CONCLUSION: During the postoperative follow-up period of 6-36 months, 20 patients presented with different degrees of liver dysfunction at 4 weeks-6 months. After drug treatment, liver function recovered to normal level. At 1.5 years after kidney transplantation, one patient died of severe liver failure due to changing his anti-rejection program by himself. Four patients presented with HCV RNA-negative symptoms after using interferon combined with ribavirin after kidney transplantation, while the remaining 18 patients remained to present HCV RNA-positive symptoms and required long-term liver treatment. These findings suggest that HCV-positive recipients should be strictly followed up after kidney transplantation to ensure that appropriate managements would be taken in time when their liver function appeared abnormal.

中图分类号: